Human Factor IX (Factor 9) ELISA Kit (with Controls)

A comprehensive model for assessment of liver stage therapies targeting Plasmodium vivax and Plasmodium falciparum

• https://www.nature.com/articles/s41467-018-04221-9
• A Roth, SP Maher, AJ Conway, R Ubalee… - Nature …, 2018 - nature.com
• Malaria liver stages represent an ideal therapeutic target with a bottleneck in parasite load and reduced clinical symptoms; however, current in vitro pre-erythrocytic (PE) models for …

Selective Microvascular Tissue Transfection Using Minicircle DNA for Systemic Delivery of Human Coagulation Factor IX in a Rat Model Using a Therapeutic Flap

• https://pubmed.ncbi.nlm.nih.gov/34757962/#affiliation-1
• Than PA et al. (2022). Plast Reconstr Surg. 149(1):117-129
• No Snippet Provided

Endoscopic-mediated, biliary hydrodynamic injection mediating clinically relevant levels of gene delivery in pig liver

• https://pubmed.ncbi.nlm.nih.gov/34197834/#affiliation-1
• Kruse RL (2021). Gastrointest Endosc. S0016-5107(21)01463-2.
• No Snippet Provided

Plasma Proteome Analyses of Experimental Human and Murine Thyroid Disease Models

• https://epub.ub.uni-greifswald.de/frontdoor/deliver/index/docId/2118/file/Dissertation_Beatrice_Engelmann.pdf
• Engelmann B (2018). Ernst Moritz Arndt University of Greifswald. Dessertation.
• No Snippet Provided

Systemic delivery of factor IX messenger RNA for protein replacement therapy

• https://www.pnas.org/doi/pdf/10.1073/pnas.1619653114
• Ramaswamya S et al. (2017). Proc Natl Acad Sci USA. 114(10):E1941-E1950.
• No Snippet Provided

Therapeutic efficacy in a hemophilia B model using a biosynthetic mRNA liver depot system

• http://www.nature.com/gt/journal/v23/n10/full/gt201646a.html
• DeRosa F et al. (2016). Gene Therapy 23:699-
• No Snippet Provided

Lipid formulations for delivery of messenger rna

• http://www.google.com.pr/patents/US20150140070
• Heartlein M et al. (2015). Patents: US 20150140070 A1.
• No Snippet Provided

Development of an efficient human hepatocyte culture platform for assessing novel therapeutic efficacy against Plasmodium liver parasites

• https://digitalcommons.usf.edu/cgi/viewcontent.cgi?article=6459&context=etd
• Maher SP (2014). University of South Florida. Graduate Theses and Dissertations.
• No Snippet Provided

Mrna therapeutic compositions and use to treat diseases and disorders

• http://www.google.com/patents/WO2014152940A1?cl=en
• Heartlein M (2014). Patent application:WO2014152940 A1
• No Snippet Provided

Lipidic nanoparticles for mrna delivering

• http://www.google.com/patents/WO2014089486A1?cl=en
• Derosa F et al.(2014). Patent application:WO2014089486 A1
• No Snippet Provided

Early detection of malignant pleural mesothelioma in asbestos-exposed individuals with a noninvasive proteomics-based surveillance tool

• https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3463527/pdf/pone.0046091.pdf
• Ostroff RM et al. (2012). PLoS One. 7(10):e46091
• No Snippet Provided

Lipid nanoparticle compositions and methods for mrna delivery

• http://www.google.com/patents/WO2012170930A1?cl=en
• Guild BC et al. (2012). Patent Application WO2012170930 A1
• No Snippet Provided

Long-Acting Coagulation Factors and Methods of Producing Same

• http://www.freepatentsonline.com/8759292.html
• Fima UE et al. (2010). Patent No: US 8476234 B2
• No Snippet Provided

Sex hormones affect the production of recombinant Factor IX in CHO and HEK-293 cell lines

• https://pubmed.ncbi.nlm.nih.gov/18581062/#affiliation-1
• Dadehbeigi N et al. (2008). Biotechnol Lett. 30(11):1909-12
• No Snippet Provided